Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EcoR1 Capital
San Francisco, California, United Statesecor1cap.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
EcoR1 Capital is an active biotech-focused investment fund based in San Francisco. It partners with and invests in innovative life sciences and biotechnology companies developing new medicines for untreated diseases. The firm leverages scientific and strategic expertise to identify promising opportunities that can transform patient outcomes.
Its portfolio includes numerous early-stage to late-stage biotech firms across various therapeutic areas. As an investor rather than a drug developer, it does not have its own clinical results or pipeline.
Recent public filings show significant investments in leading biotech firms such as AnaptysBio, Zymeworks, Sarepta Therapeutics, Apellis Pharmaceuticals, Akero Therapeutics among others.
Key people include founder Oleg Nodelman and several partners and analysts.
- Therapeutic areas
- Other
- Modalities
- Not applicable
- Industry
- Investors
02
Partnerships
Portfolio investments/partnerships with numerous biotech startups including Accent Therapeutics, Actio Biosciences, Affinia Therapeutics, Affinivax, Ajax Therapeutics, Akouos among many others
Beyond the preview
Go deeper on EcoR1 Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EcoR1 Capital.